Bristol-Myers Squibb

Bristol-Myers Squibb (NYSE: BMY) $81.1b Michael Bonney, Ms. Julia Haller, Ms. Phyllis Yale join Board / Bonney ExCOB x- CEO Kaleido Biosciences BM- Celgene, Alnylam Pharma, Magenta Thera, Sarepta Thera, Syros Pharma / Haller Ophthalmologist-in-Chief Wills Eye Hospital, Prof Sidney Kimmel Medical College Thomas Jefferson University / Yale Partner Bain, COB Blue Cross Blue Shield of MA BM- DaVita

$$$$ annual retainer of $100,000 and an annual award of deferred share units valued at $185,000

https://www.bms.com/about-us/leadership/board-of-directors.html